Artificial intelligence identifies existing drugs that may reduce sight loss from AMD

Patients regain sight after being first to receive retinal tissue engineered from stem cells

BenevolentAI and group of UK charities partner to find a cure for blindness

Charities unite to tackle leading cause of blindness

Research priorities agreed to stop early age-related macular degeneration (AMD) turning into late AM

Research priorities agreed

Setting priorities for eye research

Urgent call for more funding into macular research

Setting priorities for eye research